buparvaquone has been researched along with Canine Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Krishna, G; Narayanan, A; Panicker, VP; Pillai, UN; Rahman, S; Simon, NP; Unny, M | 1 |
| Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N | 1 |
| Croft, SL; Furtado Campos, JH; Miles, MA; Vexenat, JA | 1 |
3 other study(ies) available for buparvaquone and Canine Diseases
| Article | Year |
|---|---|
Multiple point mutations in cytochrome b gene of Babesia gibsoni - A possible cause for buparvaquone resistance.
Topics: Animals; Anti-Infective Agents; Azithromycin; Babesia; Babesiosis; Cytochromes b; Dog Diseases; Dogs; Point Mutation | 2022 |
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction | 2017 |
Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Naphthoquinones | 1998 |